Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update
11 août 2021 07h32 HE
|
Diffusion Pharmaceuticals Inc.
Reports Improved Outcomes in Phase 1b COVID-19 Study and Positive Trend in Peripheral Oxygenation in Phase 1b TCOM StudyExpects to Announce Initial Indication and Regulatory Pathway in Fourth Quarter...